Skip to main content
SpringerLink
Log in

Extracorporeal Artificial Liver Support Systems

  • Chapter
  • First Online:
Chronic Liver Failure

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

One of the most appealing therapeutic approaches for treating any organ failure is the possibility to provide a temporary artificial support of its function. In some cases (for example kidney failure) dialysis procedures are widely accepted and used, while in others (for example cardiac failure) artificial devices remain largely investigational. In this context, the concept of artificial liver support (ALS) has gained importance in the past decades.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kim WR, Brown RS, Jr., Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36: 227–42.

    Article  PubMed  Google Scholar 

  2. Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther 2006; 23: 351–63.

    Article  CAS  PubMed  Google Scholar 

  3. Palmes D, Skawran S, Spiegel HU. Acute liver failure: from bench to bedside. Transplant Proc 2005; 37: 1628–31.

    Article  CAS  PubMed  Google Scholar 

  4. Palmes D, Qayumi AK, Spiegel HU. Liver bridging techniques in the treatment of acute liver failure. J Invest Surg 2000; 13: 299–311.

    Article  PubMed  Google Scholar 

  5. Rajvanshi P, Larson AM, Kowdley KV. Temporary support for acute liver failure. J Clin Gastroenterol 2002; 35: 335–44.

    Article  PubMed  Google Scholar 

  6. Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology 2001; 34: 447–55.

    Article  CAS  PubMed  Google Scholar 

  7. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216–30.

    Article  PubMed  Google Scholar 

  8. Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial 2006; 10: 168–74.

    Article  PubMed  Google Scholar 

  9. Park JK, Lee DH. Bioartificial liver systems: current status and future perspective. J Biosci Bioeng 2005; 99: 311–9.

    Article  CAS  PubMed  Google Scholar 

  10. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23: 319–30.

    Article  CAS  PubMed  Google Scholar 

  11. Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, et al. Detoxifying capacity and kinetics of prometheus – a new extracorporeal system for the treatment of liver failure. Blood Purif 2005; 23: 349–58.

    Article  CAS  PubMed  Google Scholar 

  12. Sen S, Jalan R, Williams R. Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system. Int J Biochem Cell Biol 2003; 35: 1306–11.

    Article  CAS  PubMed  Google Scholar 

  13. Koivusalo AM, Teikari T, Hockerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008; 23: 387–98.

    Article  CAS  PubMed  Google Scholar 

  14. Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D. Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol 2006; 12: 940–4.

    PubMed  Google Scholar 

  15. Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 2006; 30: 276–84.

    Article  CAS  PubMed  Google Scholar 

  16. Stadlbauer V, Krisper P, Beuers U, Haditsch B, Schneditz D, Jung A, Putz-Bankuti C, et al. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. Asaio J 2007; 53: 187–93.

    Article  CAS  PubMed  Google Scholar 

  17. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 2002; 22(Suppl 2): 5–13.

    PubMed  Google Scholar 

  18. Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004; 10: 1109–19.

    Article  PubMed  Google Scholar 

  19. Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006; 10: R169.

    Article  PubMed  Google Scholar 

  20. Di Campli C, Zocco MA, Gaspari R, Novi M, Candelli M, Santoliquido A, Flore R, et al. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplant Proc 2005; 37: 2551–3.

    Article  PubMed  Google Scholar 

  21. Saich R, Selden C, Rees M, Hodgson H. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy. Artif Organs 2007; 31: 732–42.

    Article  CAS  PubMed  Google Scholar 

  22. Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, et al. Pro-inflammatory interleukin-18 and caspase-1 serum levels in liver failure are unaffected by MARS treatment. Dig Liver Dis 2009; 41: 417–23.

    Google Scholar 

  23. Catalina MV, Barrio J, Anaya F, Salcedo M, Rincon D, Clemente G, Banares R. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int 2003; 23(Suppl 3): 39–43.

    CAS  PubMed  Google Scholar 

  24. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10: R108.

    Article  PubMed  Google Scholar 

  25. Pugliese F, Novelli G, Poli L, Levi Sandri GB, Di Folco G, Ferretti S, Morabito V, et al. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Transplant Proc 2008; 40: 1925–8.

    Article  CAS  PubMed  Google Scholar 

  26. Sen S, Mookerjee RP, Cheshire LM, Davies NA, Williams R, Jalan R. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005; 43: 142–8.

    Article  CAS  PubMed  Google Scholar 

  27. Dethloff T, Tofteng F, Frederiksen HJ, Hojskov M, Hansen BA, Larsen FS. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol 2008; 14: 2065–71.

    Article  PubMed  Google Scholar 

  28. Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, Muravsky V, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology 2009; 50: 555–64.

    Article  CAS  PubMed  Google Scholar 

  29. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, et al. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000; 6: 603–13.

    Article  CAS  PubMed  Google Scholar 

  30. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26: 103–10.

    Article  PubMed  Google Scholar 

  31. Wilmer A, Nevens F, Evenepoel P, Hermans G, Fevery J. The molecular adsorbent recirculating system in patients with severe liver failure: clinical results at the K.U. Leuven. Liver 2002; 22(Suppl 2): 52–5.

    CAS  PubMed  Google Scholar 

  32. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277–86.

    Article  CAS  PubMed  Google Scholar 

  33. Wing F, Raina N, Richardson R. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in cirrhotic patients with ascites who have failed vasoconstrictor therapy. Gut 2010; 59: 381–6.

    Google Scholar 

  34. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36: 949–58.

    CAS  PubMed  Google Scholar 

  35. Hassanein TI, Tofteng F, Brown RS, Jr., McGuire B, Lynch P, Mehta R, Larsen FS, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46: 1853–62.

    Article  CAS  PubMed  Google Scholar 

  36. Ferenci P, Kramer L. MARS and the failing liver – any help from the outer space? Hepatology 2007; 46: 1682–4.

    Article  PubMed  Google Scholar 

  37. Hessel FP. Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Cost Eff Resour Alloc 2006; 4: 16.

    Article  PubMed  Google Scholar 

  38. Doria C, Marino IR. Bacteremia using the molecular adsorbent recirculating system in patients bridged to liver transplantation. Exp Clin Transplant 2005; 3: 289–92.

    PubMed  Google Scholar 

  39. Sanz-Garcia C, Catalina MV, Gomez-Camarero J, Rincon D, Salcedo M, Lo lacono O, Clemente G, et al. Incidence and predictive factors of infection during MARS therapy. J Hepatol 2007; 46: S75–6.

    Article  Google Scholar 

  40. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140–8.

    Article  PubMed  Google Scholar 

  41. Fernandez J, Ruiz del Arbol L, Gomez C, Durandez R, Serradilla R, Guarner C, Planas R, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006; 131: 1049–56; quiz 1285.

    Article  CAS  PubMed  Google Scholar 

  42. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Mullhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007; 27: 475–84.

    Article  CAS  PubMed  Google Scholar 

  43. Meijers BK, Verhamme P, Nevens F, Hoylaerts MF, Bammens B, Wilmer A, Arnout J, et al. Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transplant 2007; 7: 2195–9.

    Article  CAS  PubMed  Google Scholar 

  44. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217–22.

    Article  PubMed  Google Scholar 

  45. Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl 2004; 10: 1099–106.

    Article  PubMed  Google Scholar 

  46. Matsubara S, Okabe K, Ouchi K, Miyazaki Y, Yajima Y, Suzuki H, Otsuki M, et al. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 1990; 18: 1331–8.

    Article  CAS  PubMed  Google Scholar 

  47. Agarwal R, Farber MO. Is continuous veno-venous hemofiltration for acetaminophen-induced acute liver and renal failure worthwhile? Clin Nephrol 2002; 57: 167–70.

    CAS  PubMed  Google Scholar 

  48. Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol 2001; 96: 1217–23.

    Article  CAS  PubMed  Google Scholar 

  49. Sadamori H, Yagi T, Inagaki M, Shima Y, Matsuda H, Tanaka N, Sakaguchi K, et al. High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure. Eur J Gastroenterol Hepatol 2002; 14: 435–9.

    Article  PubMed  Google Scholar 

  50. Mori T, Eguchi Y, Shimizu T, Endo Y, Yoshioka T, Hanasawa K, Tani T. A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation. Ther Apher 2002; 6: 463–6.

    Article  PubMed  Google Scholar 

  51. O’Grady JG, Gimson AE, O’Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186–92.

    PubMed  Google Scholar 

  52. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994; 18: 355–62.

    Article  CAS  PubMed  Google Scholar 

  53. Lanjuan L, Qian Y, Jianrong H, Xiaowei X, Yuemei C, Yagang C, Weihang M, et al. Severe hepatitis treated with an artificial liver support system. Int J Artif Organs 2001; 24: 297–303.

    CAS  PubMed  Google Scholar 

  54. Ash SR. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 2002; 9: 3–18.

    Article  PubMed  Google Scholar 

  55. Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003; 38: 24–31.

    Article  CAS  PubMed  Google Scholar 

  56. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446–51.

    Article  CAS  PubMed  Google Scholar 

  57. Millis J, Kramer D, O’Grady J. Results of phase I trial of the extracorporeal liver assist device in acute liver failure. Am J Transplant 2001; 1: 391.

    Google Scholar 

  58. Demetriou AA, Brown RS, Jr., Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS, 2nd, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660–667; discussion 667–670

    Article  PubMed  Google Scholar 

  59. Samuel D, Ichai P, Feray C, Saliba F, Azoulay D, Arulnaden JL, Debat P, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation 2002; 73: 257–64.

    Article  CAS  PubMed  Google Scholar 

  60. Mazariegos GV, Kramer DJ, Lopez RC, Shakil AO, Rosenbloom AJ, DeVera M, Giraldo M, et al. Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients. Asaio J 2001; 47: 471–5.

    Article  CAS  PubMed  Google Scholar 

  61. Xue YL, Zhao SF, Luo Y, Li XJ, Duan ZP, Chen XP, Li WG, et al. TECA hybrid artificial liver support system in treatment of acute liver failure. World J Gastroenterol 2001; 7: 826–9.

    CAS  PubMed  Google Scholar 

  62. Morsiani E, Pazzi P, Puviani AC, Brogli M, Valieri L, Gorini P, Scoletta P, et al. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002; 25: 192–202.

    CAS  PubMed  Google Scholar 

  63. Mundt A, Puhl G, Muller A, Sauer I, Muller C, Richard R, Fotopoulou C, et al. A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support. Int J Artif Organs 2002; 25: 542–8.

    CAS  PubMed  Google Scholar 

  64. Sauer IM, Zeilinger K, Obermayer N, Pless G, Grunwald A, Pascher A, Mieder T, et al. Primary human liver cells as source for modular extracorporeal liver support–a preliminary report. Int J Artif Organs 2002; 25: 1001–5.

    CAS  PubMed  Google Scholar 

  65. Ding YT, Qiu YD, Chen Z, Xu QX, Zhang HY, Tang Q, Yu DC. The development of a new bioartificial liver and its application in 12 acute liver failure patients. World J Gastroenterol 2003; 9: 829–32.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Unit, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, CIBEREHD (Centro de Investigación Biomédica en Red). Instituto de Salud Carlos III. Spain, c/ Dr. Esquerdo 46, 28007, Madrid, Spain

    Rafael Bañares & María-Vega Catalina

Authors
  1. Rafael Bañares
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María-Vega Catalina
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Liver Unit, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona, 08036, Spain

    Pere Ginès

  2. College of Medicine, Division of Gastroenterology and Hepatol, Mayo Clinic, 200 First St. S.W, Rochester, 55905, Minnesota, USA

    Patrick S. Kamath

  3. Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, 08036, Spain

    Vicente Arroyo

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bañares, R., Catalina, MV. (2011). Extracorporeal Artificial Liver Support Systems. In: Ginès, P., Kamath, P., Arroyo, V. (eds) Chronic Liver Failure. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60761-866-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-866-9_25

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-865-2

  • Online ISBN: 978-1-60761-866-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation